Co-Authors
This is a "connection" page, showing publications co-authored by Lorenzo Dagna and Evangelos Giamarellos-Bourboulis.
Connection Strength
0.301
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
Score: 0.241
-
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol. 2021 Oct; 3(10):e690-e697.
Score: 0.060